Stealth BioTherapeutics to Present New Bevemipretide Data at ARVO Annual Meeting
NEEDHAM, Mass., April 24, 2025 /PRNewswire/ -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth"), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases